Organophosphorus-induced extrapyramidal intermediate syndrome in an adolescent suicide attempt survivor

Organophosphorus Compound Induced 'Intermediate Syndrome'

Possible sertraline-induced extrapyramidal adverse effects in an adolescent

Sertraline has been considered to be a relatively safe selective serotonin reuptake inhibitor for adolescents for a long time. We report herein a case of a 16-year-old Chinese boy with depression who experienced extrapyramidal-like effects, for example, facial spasm, upper limb dystonia, akathisia, and other disturbed behaviors, while being treated with sertraline 200 mg per day. His movement s...

Organophosphorus poisoning and intermediate neurotoxic syndrome.

Very few cases of the "intermediate neurotoxic syndrome", a type of neurotoxic effect or organophosphate compound have been reported in the literature. We are reporting a case that developed the clinical features of such type of neurotoxic effect after 55 hours of taking the organophosphorus compound.

Acute Organophosphate Poisoning Induced Extrapyramidal Syndrome: A Case Report

Background: Organophosphorus compound ingestion is one of the most common modes of deliberate self-harm in developing countries like India. Neurological complications are known in acute, intermediate and delayed phases following organophosphate poisoning. However, extrapyramidal manifestations are rarely reported. Case presentation: A 30-year-old male patient was brought...

Takotsubo cardiomyopathy induced by a suicide attempt.

A 53-year-old male with no previous cardiovascular history was transferred from a psychiatric ward for urgent angiography with a diagnosis of acute coronary syndrome (ACS). The prior admission was due to a suicide attempt as a result of bipolar affective disease. The patient had been treated with paroxetine but had discontinued the therapy two months before the suicide attempt. As a result of j...